Free Trial

Ryan Specialty Holdings Inc. (NYSE:RYAN) Receives $74.83 Average PT from Analysts

Ryan Specialty logo with Finance background

Key Points

  • Ryan Specialty Holdings Inc. has received a consensus recommendation of "Moderate Buy" from twelve brokerages, with an average twelve-month price target of $74.83.
  • Insider transactions indicate some executives have sold significant shares, with EVP Mark Stephen Katz selling 14,377 shares and Director David P. Bolger selling 5,000 shares, reducing their ownership stakes.
  • The company reported earnings per share of $0.66 for the last quarter, matching analysts' expectations, with a revenue increase of 23% year-over-year.
  • Interested in Ryan Specialty? Here are five stocks we like better.

Ryan Specialty Holdings Inc. (NYSE:RYAN - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve analysts that are currently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $74.8333.

RYAN has been the topic of several research analyst reports. UBS Group decreased their price target on Ryan Specialty from $84.00 to $80.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Citigroup initiated coverage on Ryan Specialty in a research note on Wednesday, August 13th. They set a "buy" rating and a $74.00 price target on the stock. Barclays reduced their target price on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating on the stock in a research note on Monday, July 7th. Wells Fargo & Company lowered their target price on Ryan Specialty from $63.00 to $60.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Finally, The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and increased their target price for the company from $74.00 to $81.00 in a report on Tuesday, May 13th.

Read Our Latest Analysis on Ryan Specialty

Insider Buying and Selling

In related news, EVP Mark Stephen Katz sold 14,377 shares of Ryan Specialty stock in a transaction dated Friday, June 13th. The stock was sold at an average price of $65.84, for a total value of $946,581.68. Following the completion of the transaction, the executive vice president directly owned 1,117 shares in the company, valued at approximately $73,543.28. This trade represents a 92.79% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 52.21% of the company's stock.

Institutional Trading of Ryan Specialty

Large investors have recently added to or reduced their stakes in the business. Munro Partners bought a new stake in Ryan Specialty during the second quarter worth approximately $1,342,000. State of Wyoming acquired a new position in Ryan Specialty during the second quarter worth $62,000. Captrust Financial Advisors increased its stake in shares of Ryan Specialty by 0.5% in the second quarter. Captrust Financial Advisors now owns 462,320 shares of the company's stock worth $31,433,000 after purchasing an additional 2,207 shares during the period. Vident Advisory LLC bought a new position in shares of Ryan Specialty in the second quarter worth about $301,000. Finally, Snowden Capital Advisors LLC lifted its holdings in shares of Ryan Specialty by 1.3% during the second quarter. Snowden Capital Advisors LLC now owns 21,135 shares of the company's stock worth $1,437,000 after buying an additional 264 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Stock Performance

NYSE RYAN traded down $0.28 on Friday, hitting $55.15. 345,573 shares of the company's stock were exchanged, compared to its average volume of 1,074,129. The company has a debt-to-equity ratio of 2.88, a current ratio of 1.01 and a quick ratio of 1.01. The firm's 50-day moving average price is $62.17 and its two-hundred day moving average price is $66.92. Ryan Specialty has a fifty-two week low of $55.07 and a fifty-two week high of $77.16. The firm has a market cap of $14.54 billion, a price-to-earnings ratio of 157.62, a P/E/G ratio of 1.57 and a beta of 0.63.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $0.66 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.66. The company had revenue of $855.17 million for the quarter, compared to analysts' expectations of $837.52 million. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The firm's quarterly revenue was up 23.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.58 EPS. On average, research analysts expect that Ryan Specialty will post 2.29 EPS for the current year.

Ryan Specialty Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 26th. Investors of record on Tuesday, August 12th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Tuesday, August 12th. Ryan Specialty's dividend payout ratio (DPR) is 137.14%.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Read More

Analyst Recommendations for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Are Sliding: Where to Find Opportunity
5 Hot Stocks to Buy Now: September’s Top Picks With Major Momentum
$15 Billion for Cybersecurity: The Government’s Next Big Push

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines